Mereo BioPharma Group plc - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
MREO Nasdaq 2830 www.mereobiopharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Mereo BioPharma Group plc

Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights - Aug 11th, 2026 6:15 am
Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD) - Aug 11th, 2026 6:00 am
Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD) - Aug 11th, 2026 6:00 am
European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading - Jun 15th, 2026 9:09 am
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - Jun 2nd, 2026 9:08 am
Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates - May 12th, 2026 5:30 am
We're Hopeful That Mereo BioPharma Group (NASDAQ:MREO) Will Use Its Cash Wisely - Apr 7th, 2026 7:39 am
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - Apr 2nd, 2026 9:09 am
European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading - Feb 24th, 2026 9:03 am
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading - Feb 11th, 2026 9:05 am
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading - Feb 9th, 2026 9:12 am
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - Feb 4th, 2026 9:13 am
European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - Feb 3rd, 2026 9:10 am
Mereo BioPharma Group (MREO) Is Up 74.4% After Mixed Setrusumab Phase 3 Data and Cash Update – Has The Bull Case Changed? - Jan 16th, 2026 6:05 am
A Look At Mereo BioPharma (MREO) Valuation After Mixed Setrusumab Phase 3 Update And Conference Spotlight - Jan 15th, 2026 5:10 am
Mereo BioPharma Provides Corporate Update - Jan 12th, 2026 6:00 am